In an effort to foster greater transparency of healthcare costs, the government and private sector entities are offering tools that provide cost and quality information to consumers. But just how effective are these tools?
In an effort to foster greater transparency of healthcare costs, the government and private sector entities are offering tools that provide cost and quality information to consumers.
Just how effective are the tools offered by CMS? A new report from the Government Accountability Office (GAO) says that the government is failing to actually make healthcare costs more transparent.
GAO analyzed 5 transparency tools operated by CMS: Nursing Home Compare, Dialysis Facility Compare, Home Health Compare, Hospital Compare, and Physician Compare. Three other tools are under development: Hospice Quality Reporting, Inpatient Rehabilitation Facility Quality Reporting, and Long-Term Acute Care Hospital Quality Reporting.
After literature review and interviews with experts, GAO determined the information that is most relevant to consumers relates to their particular circumstances. As such, relevant information typically describes key differences in quality of care and costs.
“Transparency tools are most effective if they provide information relevant to consumers and convey information in a way that consumers can readily understand,” according to the report.
However, the tools already in place lack relevant information on cost, and data on the key differences in quality of care is limited, according to the GAO report. Furthermore, none of the tools provide information on out-of-pocket costs, so consumers cannot anticipate cost of services in advance. There was also an issue with the timeliness of the data being presented and the clarity of the language, according to the report.
Although CMS has taken some steps to expand access to cost and quality information, its process for selecting cost and quality measures for its tools has been influenced far more by providers rather than consumers.
“Without procedures or metrics focusing on consumer needs, CMS cannot ensure that these efforts will produce cost and quality information that is relevant and understandable to consumers seeking to make meaningful distinctions.”
Based on GAO’s research, more effective consumer transparency tools are:
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen